HSP90AB1 and diffuse large B-cell lymphoma: In contrast, HSP90 and sirtuin inhibitor combinations did not synergize in OxPhos-independent DLBCL cell lines (DHL4, DHL6, Ly1, Supplementary Fig. S7B).